Centiva Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-28,000
Closed -$2.02M – 1979
2022
Q1
$2.02M Sell
28,000
-34,300
-55% -$2.47M 0.04% 431
2021
Q4
$5.72M Buy
62,300
+55,420
+806% +$6.62M 0.12% 165
2021
Q3
$872K Sell
6,880
-76,420
-92% -$11.1M 0.05% 381
2021
Q2
$13.8M Buy
83,300
+53,300
+178% +$8.64M 0.33% 52
2021
Q1
$5.45M Buy
30,000
+27,000
+900% +$6.26M 0.21% 82
2020
Q4
$600K Buy
+3,000
New +$610K 0.02% 402
2019
Q4
– Sell
-18,500
Closed -$1.25M – 927
2019
Q3
$1.25M Buy
+18,500
New +$1.22M 0.08% 199

Other funds holding TDOC

Centiva Capital's TDOC Position: Q2 2026 in Review

Centiva Capital held its Teladoc Health (TDOC) position steady in Q2 2026 at 20,000 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Centiva Capital first reported a position in TDOC in Q3 2019 and has held it in 15 quarters since. The position peaked at $5.72M in Q3 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Centiva Capital held 20,000 shares of Teladoc Health worth $170K as of Q2 2026.
  • Centiva Capital left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1448 holding.
  • Centiva Capital first reported a position in Teladoc Health in Q3 2019 and has held it in 15 quarters since.
  • Centiva Capital's Teladoc Health position peaked at $5.72M in Q3 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.